did not achieve significanceP = 0.15
The primary composite outcome did not achieve significance; 3.2% of patients in the n-3 PUFA arm developed the primary composite outcome, compared to 3.6% in the placebo group ( P = 0.15).
The primary composite outcome did not achieve significance; 3.2% of patients in the n-3 PUFA arm developed the primary composite outcome, compared to 3.6% in the placebo group ( P = 0.15).